Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 4Completed 2Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Classical hematology 4Gastrointestinal 2Lymphoid 1

Conditions

Thrombocytopenia 4Carcinoma, Hepatocellular 2Lymphoma 1Chemotherapy-induced Thrombocytopenia 1

Interventions

avatrombopag 4hetrombopag 2eltrombopag 2raltitrexed 1oprelvekin 1Radiotherapy 1Moxibustion 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Thrombocytopenia × avatrombopag × Clear all
NCT06001567 2023-09-14

Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC

Second Affiliated Hospital of Guangzhou Medical University

Phase 2 Unknown
30 enrolled
Classical hematologyGastrointestinal

Carcinoma, Hepatocellular, Thrombocytopenia

NCT05087459 2021-10-21

Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma

Shanghai Zhongshan Hospital

Unknown
141 enrolled
Classical hematologyGastrointestinal

Carcinoma, Hepatocellular, Thrombocytopenia

NCT04896528 2021-05-21

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

Peking Union Medical College Hospital

Phase 2 Unknown
30 enrolled
Classical hematology

Thrombocytopenia

NCT04797182 2021-03-15

Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Sun Yat-sen University

Phase 2 Unknown
46 enrolled
Classical hematologyLymphoid

Lymphoma, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡